Loading page…
Healthcare
Jiangsu Hengrui Pharmaceuticals Co.,Ltd achieves an AlphaScore of 67/100 in the Healthcare sector. The October 11, 2026 snapshot highlights a high gross margin of 86.21% and a net margin of 24.38%. A major strength is its exceptional gross margin, reflecting advantageous product pricing and cost control. Conversely, a key risk is the elevated price-to-earnings ratio of 37.88, which suggests a rich valuation relative to current earnings.
Written 11/10/2026, 00:34:33 UTC · Snapshot 11/10/2026